Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya
<br><strong>Background<br></strong> Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract disease in early life and a target for vaccine prevention. Data on the age-prevalence of RSV specific antibodies will inform on optimizing vaccine delivery....
Κύριοι συγγραφείς: | Nyiro, JU, Kombe, IK, Sande, CJ, Kipkoech, J, Kiyuka, PK, Onyango, CO, Munywoki, PK, Nokes, DJ, Kinyanjui, TM |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Public Library of Science
2017
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya
ανά: Nyiro, J, κ.ά.
Έκδοση: (2019) -
Absence of association between cord specific antibody levels and severe respiratory syncytial virus (RSV) disease in early infants: A case control study from coastal Kenya
ανά: Nyiro, J, κ.ά.
Έκδοση: (2016) -
Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya. [version 1; peer review: 2 approved, 2 approved with reservations]
ανά: Joyce U. Nyiro, κ.ά.
Έκδοση: (2019-02-01) -
Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya
ανά: Nyiro, JU, κ.ά.
Έκδοση: (2022) -
The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya.
ανά: Rachel Ochola, κ.ά.
Έκδοση: (2009-12-01)